UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells

Blood, 2008-01, Vol.111 (2), p.846-855

2008

Volltextzugriff (PDF)

MAGE-A Tumor Antigens Target p53 Transactivation Function through Histone Deacetylase Recruitment and Confer Resistance to Chemotherapeutic Agents

Proceedings of the National Academy of Sciences - PNAS, 2006-07, Vol.103 (30), p.11160-11165

2006

Volltextzugriff (PDF)

p66Shc deficiency in the Eμ-TCL1 mouse model of chronic lymphocytic leukemia enhances leukemogenesis by altering the chemokine receptor landscape

Haematologica (Roma), 2019-10, Vol.104 (10), p.2040-2052

2019

Volltextzugriff (PDF)

A Specific CD44lo CD25lo Subpopulation of Regulatory T Cells Inhibits Anti-Leukemic Immune Response and Promotes the Progression in a Mouse Model of Chronic Lymphocytic Leukemia

Frontiers in immunology, 2022-02, Vol.13, p.781364-781364

2022

Volltextzugriff (PDF)

Inhibition of thioredoxin-dependent H2O2 removal sensitizes malignant B-cells to pharmacological ascorbate

Redox biology, 2019-02, Vol.21, p.101062-101062, Article 101062

2019

Volltextzugriff (PDF)

Wiskott-Aldrich syndrome protein-mediated actin dynamics control type-I interferon production in plasmacytoid dendritic cells

The Journal of experimental medicine, 2013-02, Vol.210 (2), p.355-374

2013

Volltextzugriff (PDF)

Signal-dependent and signal-independent functions of the B-cell receptor in chronic lymphocytic leukemia

Haematologica (Roma), 2014-11, Vol.99 (11), p.1645-1646

2014

Volltextzugriff (PDF)

FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy

Oncoimmunology, 2018-05, Vol.7 (5), p.e1423183-e1423183

2018

Volltextzugriff (PDF)

Phosphorylation of the activation loop tyrosines is required for sustained Syk signaling and growth factor-independent B-cell proliferation

Cellular signalling, 2009-07, Vol.21 (7), p.1187-1194

2009

Volltextzugriff (PDF)

The Aurora A and B kinases are up-regulated in bone marrow-derived chronic lymphocytic leukemia cells and represent potential therapeutic targets

Haematologica (Roma), 2012-08, Vol.97 (8), p.1246-1254

2012

Volltextzugriff (PDF)

BCR signaling inhibitors differ in their ability to overcome Mcl-1–mediated resistance of CLL B cells to ABT-199

Blood, 2016-06, Vol.127 (25), p.3192-3201

2016

Volltextzugriff (PDF)

Macrophage- and BCR-derived but not TLR-derived signals support the growth of CLL and Richter syndrome murine models in vivo

Blood, 2022-12, Vol.140 (22), p.2335-2347

2022

Volltextzugriff (PDF)

Bruton's tyrosine kinase (BTK) function is important to the development and expansion of chronic lymphocytic leukemia (CLL)

Blood, 2014-02, Vol.123 (8), p.1207-1213

2014

Volltextzugriff (PDF)

ZAP-70 enhances B-cell–receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells

Blood, 2007-03, Vol.109 (5), p.2032-2039

2007

Volltextzugriff (PDF)

Overexpression of the autoimmunity-associated phosphatase PTPN22 promotes survival of antigen-stimulated CLL cells by selectively activating AKT

Blood, 2012-06, Vol.119 (26), p.6278-6287

2012

Volltextzugriff (PDF)

Serum IgM Activates BCR Signaling Pathways and Increases Survival of Chronic Lymphocytic Leukemia B Cells

Blood, 2015-12, Vol.126 (23), p.4131-4131

2015

Volltextzugriff (PDF)

Hyper-Activation of the Adenosinergic Axis in the Eμ-TCL1 Chronic Lymphocytic Leukemia Mouse Model Offers Therapeutic Opportunities

Blood, 2017-12, Vol.130, p.1721-1721

2017

Volltextzugriff (PDF)

The Bcl-2 BH4 Antagonist Bda-366 Induces Apoptosis in CLL and DLBCL Cells through a Bcl-2 Independent Mechanism

Blood, 2016-12, Vol.128 (22), p.2014-2014

2016

Volltextzugriff (PDF)

FcμR Triggering Activates BCR Signaling Pathways and Increases Survival of CLL Cells

Blood, 2016-12, Vol.128 (22), p.2015-2015

2016

Volltextzugriff (PDF)

Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL

Blood, 2015-03, Vol.125 (10), p.1578-1588

2015

Volltextzugriff (PDF)

Inhibition of SYK More Effectively Overcomes MCL-1 Mediated ABT-199 Resistance of BCR-Stimulated CLL Cells Than Inhibition of BTK or PI3Kdelta

Blood, 2015-12, Vol.126 (23), p.489-489

2015

Volltextzugriff (PDF)

Serum IgM/Fcmr Interactions Inhibit BCR Signaling and Influence the Cinical Course of CLL

Blood, 2018-11, Vol.132 (Supplement 1), p.4409-4409

2018

Volltextzugriff (PDF)

TLR9 signaling defines distinct prognostic subsets in CLL

Frontiers in bioscience, 2013-01, Vol.18 (1), p.371-386

2013

Volltextzugriff (PDF)

Signaling pathways activated by antigen-receptor engagement in chronic lymphocytic leukemia B-cells

Autoimmunity reviews, 2007-12, Vol.7 (2), p.102-108

2007

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(47)

Sprache

Englisch
(47)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells

MAGE-A Tumor Antigens Target p53 Transactivation Function through Histone Deacetylase Recruitment and Confer Resistance to Chemotherapeutic Agents

p66Shc deficiency in the Eμ-TCL1 mouse model of chronic lymphocytic leukemia enhances leukemogenesis by altering the chemokine receptor landscape

A Specific CD44lo CD25lo Subpopulation of Regulatory T Cells Inhibits Anti-Leukemic Immune Response and Promotes the Progression in a Mouse Model of Chronic Lymphocytic Leukemia

Inhibition of thioredoxin-dependent H2O2 removal sensitizes malignant B-cells to pharmacological ascorbate

Wiskott-Aldrich syndrome protein-mediated actin dynamics control type-I interferon production in plasmacytoid dendritic cells

Signal-dependent and signal-independent functions of the B-cell receptor in chronic lymphocytic leukemia

FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy

Phosphorylation of the activation loop tyrosines is required for sustained Syk signaling and growth factor-independent B-cell proliferation

The Aurora A and B kinases are up-regulated in bone marrow-derived chronic lymphocytic leukemia cells and represent potential therapeutic targets

BCR signaling inhibitors differ in their ability to overcome Mcl-1–mediated resistance of CLL B cells to ABT-199

Macrophage- and BCR-derived but not TLR-derived signals support the growth of CLL and Richter syndrome murine models in vivo

Bruton's tyrosine kinase (BTK) function is important to the development and expansion of chronic lymphocytic leukemia (CLL)

ZAP-70 enhances B-cell–receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells

Overexpression of the autoimmunity-associated phosphatase PTPN22 promotes survival of antigen-stimulated CLL cells by selectively activating AKT

Serum IgM Activates BCR Signaling Pathways and Increases Survival of Chronic Lymphocytic Leukemia B Cells

Hyper-Activation of the Adenosinergic Axis in the Eμ-TCL1 Chronic Lymphocytic Leukemia Mouse Model Offers Therapeutic Opportunities

The Bcl-2 BH4 Antagonist Bda-366 Induces Apoptosis in CLL and DLBCL Cells through a Bcl-2 Independent Mechanism

FcμR Triggering Activates BCR Signaling Pathways and Increases Survival of CLL Cells

Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL

Inhibition of SYK More Effectively Overcomes MCL-1 Mediated ABT-199 Resistance of BCR-Stimulated CLL Cells Than Inhibition of BTK or PI3Kdelta

Serum IgM/Fcmr Interactions Inhibit BCR Signaling and Influence the Cinical Course of CLL

TLR9 signaling defines distinct prognostic subsets in CLL

Inhibition of thioredoxin-dependent H 2 O 2 removal sensitizes malignant B-cells to pharmacological ascorbate

Signaling pathways activated by antigen-receptor engagement in chronic lymphocytic leukemia B-cells

Suchergebnisse filtern